Bristol-Myers Squibb is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.
Bristol-Myers Squibb is a publicly traded company on PNK using the ticker symbol BMY.
Detailed information on company financials and operating reports can be found here:
PNK: BMY
Bristol-Myers Squibb Annual Revenue and Growth Rate
Note: Bristol-Myers Squibb's revenues are gauged from an analysis of company filings.
Trademark Applications
Trademark applications show the products and services that Bristol-Myers Squibb is developing and marketing.
Bristol-Myers Squibb's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
EZOJAY Pharmaceutical and biological preparations for human use.
01/10/2024
AZURAJAY Pharmaceutical and biological preparations for human use.
01/10/2024
ULBEAMSA Pharmaceutical and biological preparations for human use.
01/10/2024
See all trademarks and details in the Full Report.
Market Share of Bristol-Myers Squibb's Largest Competitors
A competitive analysis shows these companies are in the same general field as Bristol-Myers Squibb, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Bristol-Myers Squibb.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Bristol-Myers Squibb and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.